Perfil
Brian Lortie is the founder of Onspira Therapeutics, Inc. (founded in 2017) where he holds the title of Chief Executive Officer & Director.
He is currently the Chief Executive Officer & Director at Uniquity Bio, Inc. Mr. Lortie's former positions include President-United States Branded Pharmaceuticals at Endo International Plc and President at Endo Pharmaceuticals, Inc.
Cargos activos de Brian Lortie
Empresas | Cargo | Inicio |
---|---|---|
Onspira Therapeutics, Inc.
Onspira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Onspira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded by Steve Tullman, Brian Lortie, Roy Clifford Levitt and Paul Barone in 2017 and is headquartered in Chester, PA. | Fundador | 01/01/2017 |
Antiguos cargos conocidos de Brian Lortie.
Empresas | Cargo | Fin |
---|---|---|
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Presidente | - |
ENDO INTERNATIONAL PLC | Corporate Officer/Principal | 05/05/2016 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 3 |
---|---|
Endo International Plc
Endo International Plc Pharmaceuticals: MajorHealth Technology Endo International Plc operates as a pharmaceutical company, which engages in the development, manufacture, and distribution of branded and generic pharmaceutical products. It operates through the following segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. The Branded Pharmaceuticals segment conducts certain operations in the U.S. through leased and owned manufacturing properties in Pennsylvania, New York and New Jersey, as well as certain administrative and R&D functions through leased properties in Pennsylvania. The Sterile Injectables segment includes manufacturing, quality assurance, research and development, and administration functions. The Generic Pharmaceuticals segment is composed of manufacturing, distribution, quality assurance and administration functions, as well as certain research and development functions. The International Pharmaceuticals segment’s operations are currently conducted through Paladin’s leased headquarters in Montreal, Canada. The company was founded in 1997 and is headquartered Dublin, Ireland. | Health Technology |
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Onspira Therapeutics, Inc.
Onspira Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Onspira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The company was founded by Steve Tullman, Brian Lortie, Roy Clifford Levitt and Paul Barone in 2017 and is headquartered in Chester, PA. | Health Technology |
- Bolsa de valores
- Insiders
- Brian Lortie